Skip to main content
Clinical Trials/EUCTR2009-011175-70-GB
EUCTR2009-011175-70-GB
Active, not recruiting
Not Applicable

A randomised factorial trial of N-acetylcysteine prophylaxis and iso-osmolar versus low-osmolar contrast media on kidney function in patients at risk of contrast induced nephropathy following cardiac catheterisation for percutaneous coronary interventions - the CON NEC T” trial - CONNECT

iverpool Heart and Chest Hospital0 sitesApril 16, 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
iverpool Heart and Chest Hospital
Status
Active, not recruiting
Last Updated
13 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 16, 2009
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
iverpool Heart and Chest Hospital

Eligibility Criteria

Inclusion Criteria

  • eGFR \< 60 ml/m (as calculated by modified MDRD equation with local laboratory correction factor)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • 1\. Patients who had coronary angiography or other procedure with contrast exposure (CTPA etc.) within 2 weeks of PCI
  • 2\. Unable to consent
  • 3\. Patients undergoing angiographic investigations as a prelude to planned cardiac surgery
  • 4\. Cardiogenic shock
  • 5\. Unlikely to attend for follow up blood tests
  • 6\. Presence of non cardiac illness that might affect life expectancy
  • 7\. Any previous allergic reaction to contrast media or NAC

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A randomised trial comparing two strategies for preventing kidney failure after angioplastyKidney function impairment/coronary artery disease/contrast-induced nephropathyUrological and Genital DiseasesDrug- and heavy-metal-induced tubulo-interstitial and tubular conditions
ISRCTN15027862iverpool Heart and Chest Hospital NHS Trust (UK)200
Completed
Not Applicable
A randomised controlled study of N-Acetylcysteine in liver transplantatioSurgery: Liver transplantSurgeryLiver transplant
ISRCTN46492332Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)170
Completed
Not Applicable
Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease.Chronic obstructive pulmonary diseaseRespiratoryPulmonary disease
ISRCTN21676344Health Research Council of New Zealand50
Recruiting
Phase 2
The Post Anaesthesia N-Acetycysteine Cognitive Evaluation trial, investigating the potential for N-Acetylcysteine to reduce cognitive dysfunction following major elective non-cardiac surgeryPost Operative Cognitive DysfunctionSurgical Stress ResponsePost Operative Mood DisorderPost surgical painAnaesthesiology - AnaestheticsMental Health - Studies of normal psychology, cognitive function and behaviourSurgery - Other surgery
ACTRN12614000411640The Geelong Hospital370
Recruiting
Phase 2
Treatment using N-acetyl cysteine (Injection) to reduce occurrence of muscle weakness and death in patients admitted with organophosphate (OP) pesticide poisoning.Health Condition 1: T600- Toxic effect of organophosphate and carbamate insecticides
CTRI/2020/09/028060Christian medical college Vellore